BAY CITY CAPITAL LLC
CIK 1288452 · last filed 2021-10-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$93.34M
Companies
12
Total Filings
23
Lifetime Open-Market Net
-$489.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XLO | 10%+ Owner | 816,990 | $8.31 | $6.79M | $5.00M | 1 | 2021-10-26 |
| MDGL | Director | 154,255 | $480.77 | $74.16M | -$586.74M | 3 | 2020-05-29 |
| IMRA | 10%+ Owner | 703,380 | $17.02 | $11.97M | $0 | 1 | 2020-03-16 |
| Kezar Life Sciences, Inc. (KZR) Delisted | 10%+ Owner | 622,229 | $7.29 | $4.54M | $2.25M | 1 | 2018-06-28 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 10,548,881 | $18.62 | $196.42M | -$2.34M | 4 | 2015-07-28 |
| NEVRO CORP (NVRO) Delisted | 42,658 | $5.84 | $249.1K | $0 | 1 | 2014-11-12 | |
| DERM | Director | 65,572 | $6.34 | $415.7K | $4.42M | 1 | 2014-10-08 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 2,221,067 | — | — | $0 | 3 | 2013-07-19 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 3,492,063 | $1.47 | $5.13M | $10.00M | 1 | 2013-06-07 |
| ReShape Weightloss Inc. (ETRM) Delisted | 10%+ Owner | 51,451 | — | — | $11.83M | 3 | 2010-12-16 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | 10%+ Owner | 219,284 | — | — | $39.52M | 2 | 2007-08-08 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | 10%+ Owner | 4,383,684 | — | — | $26.42M | 1 | 2007-04-30 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-08-08 | VIA Pharmaceuticals, Inc. (VIAP) Delisted | Buy (P) | +16,263,928 | $39.52M | EDGAR |
| 2007-06-07 | VIA Pharmaceuticals, Inc. (VIAP) Delisted | Other (J) | +33,573,708 | $0 | EDGAR |
| 2007-04-30 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +4,174,064 | $26.42M | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.